The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires.

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world.

Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.2% in the afternoon session after the company reported second-quarter financial results that surpassed Wall Street ...

Boston Scientific reported impressive Q2 2025 results with total net sales of $5.061 billion, representing a 22.8% reported growth and 17.4% organic growth year-over-year.